---
title: "YONGAN PHARMACEUTICAL: There are no significant matters related to the company that should be disclosed but have not been disclosed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243853693.md"
description: "YONGAN PHARMACEUTICAL issued a notice of unusual movement, stating that the company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment; the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage"
datetime: "2025-06-10T09:15:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243853693.md)
  - [en](https://longbridge.com/en/news/243853693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243853693.md)
generator: "portal-rs"
---

# YONGAN PHARMACEUTICAL: There are no significant matters related to the company that should be disclosed but have not been disclosed

YONGAN PHARMACEUTICAL issued a notice of unusual movement, stating that the company's recent operating conditions are normal and there have been no significant changes in the internal and external operating environment; the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage

### Related Stocks

- [002365.CN](https://longbridge.com/en/quote/002365.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [Trump Picks White House Health Adviser Heidi Overton to Lead FDA After Marty Makary’s Exit](https://longbridge.com/en/news/296315647.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [Bioextrax patent application enters regulatory review for new molasses-based PHA process](https://longbridge.com/en/news/296315743.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**